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Abstract
Growing evidence has indicated that prefibrillar form of soluble amyloid beta (sAβ1–42) is the major causative factor
in the synaptic dysfunction associated with AD. The molecular changes leading to presynaptic dysfunction caused
by sAβ1–42, however, still remains elusive. Recently, we found that sAβ1–42 inhibits chemically induced long-term
potentiation-induced synaptogenesis by suppressing the intersynaptic vesicle trafficking through calcium (Ca2+)
dependent hyperphosphorylation of synapsin and CaMKIV. However, it is still unclear how sAβ1–42 increases intracellular
Ca2+ that induces hyperphosphorylation of CaMKIV and synapsin, and what is the functional consequences of
sAβ1–42-induced defects in intersynaptic vesicle trafficking in physiological conditions. In this study, we
showed that sAβ1–42elevated intracellular Ca2+ through not only extracellular Ca2+ influx but also Ca2+ release
from mitochondria. Surprisingly, without Ca2+ release from mitochondria, sAβ1–42 failed to increase intracellular
Ca2+ even in the presence of normal extracellular Ca2+. We further found that sAβ1–42-induced mitochondria
Ca2+ release alone sufficiently increased Serine 9 phosphorylation of synapsin. By blocking synaptic vesicle reallocation,
sAβ1–42 significantly increased heterogeneity of total synaptic vesicle pool size among synapses. Together, our results
suggested that by disrupting the axonal vesicle trafficking, sAβ1–42 disabled neurons to adjust synaptic pool sizes
among synapses, which might prevent homeostatic rescaling in synaptic strength of individual neurons.
Background
Abnormal synaptic function is one of the earliest known
defects in Alzheimer’s disease (AD) [1]. Recent studies
have indicated that the non-fibrillar soluble oligomeric
form of amyloid β protein (sAβ) rather than insoluble
amyloid fibrils or plaques [2–4] is the cause of the
synaptic dysfunction and cognitive defects associated
with AD. Indeed, biochemical analysis of postmortem
AD tissue has revealed a robust correlation between sAβ
levels and the extent of synapse loss and cognitive
impairment [2]. The accumulation of sAβ also closely
correlates with cognitive decline in animal models and
AD patients and is primarily due to disrupting synaptic
plasticity [5], Ca2+ homeostasis [6–8] and signaling path-
ways such as glycogen synthase kinase 3 beta (GSK-3β)
[9], c-Jun [10], Ca2+/calmodulin-dependent protein kinase
kinase (CaMKK), AMP-activated protein kinase (AMPK)
[11], cytoskeletal networks [12] and axonal transport [13].
The 42-residue amyloid beta protein (sAβ1–42) has been
shown to impair long-term potentiation (LTP), and to
be neurotoxic [14]. A number of different postsynaptic
mechanisms, including dendritic spine loss, alteration
of 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl) propanoic
acid (AMPA) and N-methyl-D-aspartic acid (NMDA) re-
ceptor numbers have been implicated in sAβ1–42-induced
synaptic dysfunction [15–17] while the molecular changes
leading to presynaptic dysfunction by sAβ1–42 have not
been clearly identified [18–23].
Previous studies have showed that axonal synaptic
vesicles diffuse laterally along the axon and trading of
synaptic vesicles (SVs) between synapses reallocates
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functional SV pools and synaptic strength, leading to
dynamically regulate presynaptic properties [24–26].
One of physiological consequences of intersynaptic
vesicle sharing includes a rapid new functional synapse
formation upon synaptic plasticity [26, 27]. Recently, we
have found that sAβ1–42 inhibits chemical LTP (cLTP)-
induced synaptogenesis by suppressing the intersynaptic
vesicle trafficking. We further found that sAβ1–42 rapidly
increases intracellular Ca2+, which causes hyperpho-
sphorylation of synapsin and CaMKIV and this is a key
pathway responsible for the inhibitory effect of sAβ1–42
on the regulation of intersynaptic vesicle trafficking [27].
We, however, do not know how sAβ1–42 increases intra-
cellular Ca2+ which is critical for the phosphorylation-
dependent dissociation of synapsin-SV-actin ternary
complex [27]. The sharing between the SV pools over
synapse also contributes to resizing of the SV pool at a
single synapse, leading to homeostatic changes in
synaptic pool sizes in neurons [26]. Since sAβ1–42-
suppresses intersynaptic vesicle trafficking, it could
affect homeostatic regulation of SV pool size, which is
currently unknown.
In this study, we have addressed these two important
issues. We found that sAβ1–42 rapidly elevated intracellu-
lar Ca2+ through not only extracellular Ca2+ influx but
also Ca2+ release from mitochondria. Surprisingly, sAβ1–42
induced Ca2+ release from mitochondria is critical for
extracellular Ca2+ influx, and it also sufficiently hyperpho-
sphorylates synapsin which is important for intersynaptic
vesicle trafficking. We also showed that acute treatment of
sAβ1–42 to cultured rat hippocampal neurons strongly
blocked SV reallocation, leading to a significant increase
in heterogeneity in SV pool size among synapses.
Results
sAβ1–42-induced Ca
2+ release from mitochondria is critical
for extracellular Ca2+ influx
Our previous study have found that acute treatment
(2 h) of sAβ1–42 greatly increases the presynaptic Ca
2+
level, which leads to hyperphosphorylation of CaMKIV
(T196) and synapsin (S9) [27] (also confirmed in Fig. 1a).
Ca2+ and CaMKIV mediated phosphorylation of synap-
sin S9 dissociates SV-synapsin-actin ternary complex
and this is a critical pathway for sAβ1–42 effect to inhibit
intersynaptic vesicle trafficking [27]. However, the source
of cytosolic Ca2+ upraised by sAβ1–42 treatment has
remained unknown. To solve this question, we loaded
neurons with Fluo-4 AM to monitor changes in
cytosolic Ca2+ levels (Fig. 1b). sAβ1–42 markedly
increased intracellular Ca2+ after 5 min treatment in
2 mM extracellular Ca2+ concentration (Fig. 1b). Similar
to this result, phosphorylation of synapsin was also
increased after sAβ1–42 treatment (Fig. 1c). The amount
of phosphorylated synapsin by sAβ1–42 was not affected
by treatment time (3 min to 6 h) (Fig. 1c). Next, we
measured sAβ1–42-induced cytosolic Ca
2+ elevation in
real-time and found that sAβ1–42 rapidly increases intra-
cellular Ca2+ right after treatment in 2 mM extracellular
Ca2+ concentration (Fig. 1d). sAβ1–42, however, also
evoked a small but significant rises cytosolic Ca2+ even
in the absence of extracellular Ca2+ (Fig. 1d). These re-
sults suggested that sAβ1–42 increased the cytosolic Ca
2+
level by mainly inducing extracellular Ca2+ influx but
partially stimulating the other intracellular Ca2+ stores.
Mitochondria have been known to act as important in-
ternal Ca2+ source and to be dysregulated in Alzheimer’s
disease [28]. To test the effects of sAβ1–42 on mitochon-
dria Ca2+ release, we blocked mitochondrial Ca2+ efflux
by applying tetraphenylphosphonium (TPP), which
blocks Ca2+ efflux from mitochondria [29]. TPP
completely eliminated sAβ1–42-induced rise in Ca
2+signal
in the absence of extracellular Ca2+ (Fig. 1d).
Surprisingly, when mitochondria Ca2+ efflux was blocked
by TPP, cytosolic Ca2+ increment by sAβ1–42 was signifi-
cantly decreased despite the presence of 2 mM extracel-
lular Ca2+ (Fig. 1d). Furthermore, when we pretreated
carbonyl cyanide p-(trifluoromethoxy)-phenylhydrazone
(FCCP) to deplete the mitochondria Ca2+ and then
treated with sAβ1–42 (Fig. 1e), the increment of cytosolic
Ca2+ by sAβ1–42 was not observed even in the presence
of extracellular Ca2+ (Fig. 1e).
Next we tested whether mitochondrial Ca2+ release by
sAβ1–42 is sufficient to phosphorylate synapsin. We found
that phosphorylation of synapsin was signicantly increased
by sAβ1–42-induced mitochondrial Ca
2+release (without
extracellular Ca2+) and restored by TPP treatment
(Fig. 1f ). These results indicated that sAβ1–42-evoked
rise in cytosolic Ca2+ was mostly due to the Ca2+
coming from outside of the cells, but the release of
Ca2+ from the mitochondria plays an important role
to induce extracellular Ca2+ influx and could phos-
phorylates synapsin.
sAβ1–42 inhibits intersynaptic movements of synaptic
vesicle and synapsin
Since phosphorylation of synapsin is a key mechanism
for sAβ1–42-induced defect in the intersynaptic vesicle
trafficking, the overexpression of phospho-deficient
mutant of synapsin Ia completely restore the sAβ1–42-in-
duced inhibition of intersynaptic vesicle movements
[27]. Accordingly, we further found that phospho-
deficient mutant (S9A) of synapsin Ia had much higher
binding affinity for actin, which is important for
maintaining intersynaptic trafficking (Additional file 1:
Figure S1). In addition, we confirmed that sAβ1–42
strongly suppressed intersynaptic vesicle trafficking as
previously described (Fig. 2a-c) [27].
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Previous study showed that synapsin itself laterally
moves between neighboring synapses [30]. Thus, we exam-
ine the dynamic behavior of synapsin in response to sAβ1–
42 using a fluorescence recovery after photobleaching
(FRAP) and analyzed whether sAβ1–42 affects the move-
ment of synapsin as well. We transfected GFP-synapsin
into neurons, and then selectively photo-bleached a single
presynapse and monitored the recovery of fluorescence
(Fig. 2d). After photo-bleaching, substantial recovery of
GFP-synapsin fluorescence (~ 70%) was observed in the
control neurons (Fig. 2d, e). However, in boutons treated
with sAβ1–42, fluorescence recovery occurred less and
slower than in the control group (Fig. 2d-g). Preincubation
of sAβ1–42 with 6E10 antibody completely blocked the
sAβ1–42 effect (Fig. 2d-g). These data strongly suggested
that sAβ1–42 suppressed the intersynaptic movements of
both SVs and synapsin.
sAβ1–42 significantly increases heterogeneity of total SV
pools among synapses
Since the lateral trafficking and sharing of SVs among
synapses have been known to regulate presynaptic
Fig. 1 sAβ1–42 increases cytosolic Ca2+ concentration by inducing mitochondria Ca2+ release dependent extracellular Ca2+ influx. a Cultured neurons
were pretreated as indicated and analyzed for the level of each phospho-synapsin (S9) and phospho-CaMKIV (T196). b Representative images
for Fluo-4 AM after treatment with 200 nM sAβ1–42 for 5 min (Scale bar = 5 μm). c Neurons were treated with sAβ1–42 for the time as indicated
and phosphorylation of synapsin was measured by the western blot (1 ± 0 for 0 min, 1.56 ± 0.13 for 3 min, 1.73 ± 0.19 for 2 h, 1.77 ± 0.10 for
6 h sAβ1–42 treatment, n = 4 independent blots). Equal amount of HEK293T cell lysates and neuron lysates incubated with phosphatase were
loaded to confirm the synapsin and phospho-synapsin bands. d Fluo-4 AM intensity plots after treatment with 200 nM sAβ1–42 or 2 μM TPP in the
indicated extracellular buffer (in brackets). Averaged ΔF/F0 was calculated by averaging the last 20 points of fluorescence profiles (2.59 ± 0.39 for sAβ1–42 in
2 mM extracellular Ca2+, 0.43 ± 0.05 for sAβ1–42 in 0 mM extracellular Ca2+, 0.42 ± 0.08 for sAβ1–42 in 2 mM extracellular Ca2+ with TPP, 0.00 ± 0.01 for
sAβ1–42 in 0 mM extracellular Ca
2+ with TPP, 0.04 ± 0.04 for TPP in 2 mM extracellular Ca2+, 0.05 ± 0.03 for TPP in 0 mM extracellular Ca2+
(n≥ 5 independent experiments for each group)). e Fluo-4 AM loaded neurons were pretreated as indicated (in brackets) for 5 min and treated with
200 nM sAβ1–42 (Averaged ΔF/F0: 1.67 ± 0.20 for sAβ1–42 (n = 3 independent experiments), 0.00 ± 0.03 for sAβ1–42 with FCCP (n = 4
independent experiments)). f Neurons were treated with the indicated medium for 2 h and their phospho-synapsin (S9) and total synapsin
level were detected by western blot and analyzed (Phospho-synapsin/total-synapsin: 1 ± 0 for control, 1.48 ± 0.32 for control with TPP,
2.45 ± 0.11 for sAβ1–42, 1.66 ± 0.37 for sAβ1–42 with TPP, n= 3 independent blots). Values are means ± standard error of mean (SEM). N.S = no significant
difference, * p< 0.05, ** p< 0.01 (ANOVA and Tukey’s HSD post hoc test for (c, d, f) and Student’s t-test for (e))
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properties by reallocating SVs and thus balancing the SV
pool size among synaptic neighbors [24, 26, 31], we sus-
pected that the defects in lateral intersynaptic trafficking
of SV by sAβ1–42 could affect homeostatic regulation of
SV pool size among synapses.
We first stained neurons with the synaptic vesicle
marker, synaptophysin and the active zone marker, bas-
soon after treatment with or without sAβ1–42 to check if
there are any morphological changes in presynaptic
terminals. When we stained neurons with synaptophysin
antibody to measure total synaptic vesicle pool size [32–
34], we found that sAβ1–42 treated neurons showed
higher variability of the size of presynaptic boutons than
the control group, while they showed the similar number
of presynaptic boutons with the control group (Fig. 3a,
b). The intensity of bassoon, a presynaptic active zone
marker, however, was not different between sAβ1–42
treated and untreated neurons (Fig. 3c), demonstrating
that sAβ1–42 treatment increased heterogeneity of total
SV pool size without altering the morphology of
presynaptic terminals.
To confirm that this did not come from a biased under-
sampling, we plotted the pooled distribution histogram of
synaptophysin intensities obtained from over 80,000
individual boutons. We found that sAβ1–42 increased the
mean value of the total SV pool size (Fig. 3d, e). More
importantly, when the distribution of bouton intensities
was fitted to a gamma function with a fixed-shape param-
eter (α = 4), the scale parameter (β), which indicates the
degree of dispersion of the distribution, was significantly
larger in neurons exposed to sAβ1–42 than in the control
or sAβ1–42-6E10 treated group (Fig. 3d, e). These results
indicate that sAβ1–42 significantly increases heterogeneity
between presynapses and thus affects homeostatic
rescaling by inhibiting intersynaptic vesicle trafficking.
Discussion
Substantial data have indicated that sAβ1–42 causes the
synaptic dysfunction observed in AD [3]. sAβ1–42 alters
synaptic plasticity by inhibiting long-term potentiation
and facilitating long-term depression [35, 36]. These
changes induce the loss of dendritic spines, modulate
the expression of AMPA and NMDA receptors and
interfere with Ca2+ homeostasis [4, 15, 17, 37]. Much
less attention, however, has been paid to the effect of
sAβ1–42 on the presynaptic function. Moreover, there
have been highly contradictory observations about the
effects of sAβ1–42 on presynapses depending on its
source [18, 20] or concentration [18, 22]. Here, we found
that sAβ1–42 induces mitochondrial Ca
2+ release and it is
critical for extracellular Ca2+ influx across the plasma
membrane and hyperphosphorylation of synapsin. We
also have figured out that sAβ1–42 strongly increases
heterogeniety of presynaptic vesicle pool sizes by
Fig. 2 sAβ1–42 suppressed the intersynaptic vesicle movement and synapsin. a-c Neurons expressing GFP-synaptophysin were treated as indicated
and imaged for 1 min to track the intersynaptic vesicles. a Representative kymographs showing trafficking of GFP-synaptophysin in each group. b MSD
curves versus time. c Diffusion coefficients, n= 7 independent experiments for each group. d-g Neurons were transfected with GFP-synapsin (DIV8) and
treated as indicated at DIV14. A single bouton was selectively photobleached and its recovery time was measured through FRAP assay. d Representative
time-lapse images of FRAP assay for control, sAβ1–42 and sAβ1–42 with 6E10 (scale bar = 5 μm). White arrowheads indicate bleached boutons. e Average
plots of fluorescence intensities (normalized to initial intensities) before and after photobleaching. f Fluorescence recovery traces in (e) were fitted to a
single exponential function with time constant (τ) of 19.36±0.84 s for control, 28.92±1.8 s for sAβ1–42, and 21.38±1.82 s for sAβ1–42 with 6E10, respectively
(n= 4 independent experiments for each group). g Mobile fractions were calculated by averaging final 5 values in (e). Mobile fraction (%): 68.10±2.67 for
control, 55.13±5.47 for sAβ1–42, and 75.25±7.85 for sAβ1–42 with 6E10 (n= 4 independent experiments for each group). Values are means±SEM. N.S = no
significant difference, * p< 0.05, ** p < 0.01 (ANOVA and Tukey’s HSD post hoc test))
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disrupting SV pool sharing which is affected by synapsin
phosphorylation.
We also have found that sAβ1–42-mediated Ca
2+ incre-
ment is the major causative factor in the presynaptic
dysfunction associated with intersynaptic vesicle traffick-
ing [27]. However, we have not revealed the Ca2+ sources
involved in this phenomenon [27]. Although the precise
mechanism is still elusive, previous studies have suggested
that sAβ1–42 trigger not only internal Ca
2+release from
endoplasmic reticulum (ER) [38] but also extracellular Ca2
+ influx by altering membrane Ca2+permeability, interact-
ing with voltage-gated Ca2+channels or forming Aβ pores,
[7, 39]. Here, we found that extracellular Ca2+ made up a
large portion of the total Ca2+ incremented by sAβ1–42
treatment, whereas small but significant portion was con-
stituted by Ca2+released from mitochondria. In addition,
mitochondria Ca2+ efflux was required for the extracellu-
lar Ca2+ influx by sAβ1–42. Although the precise molecular
mechanism of how released Ca2+ from mitochondria in-
duces extracellular Ca2+ influx certainly requires further
study, we could speculate some possibilities. The released
Ca2+ from mitochondria by sAβ1–42 could act as a signal-
ing molecule and activates some Ca2+ channels in plasma
membrane. For example, previous study indicates that
mitochondrial Ca2+ released by FCCP activates extracellu-
lar signal regulated kinase (ERK) 1/2 in PC12 cells [40].
Indeed, ERK phosphorylates α1 and β subunits of N-type
VDCCs (voltage-dependent calcium channels) [41] and
enhances VDCC current in sensory neurons [42]. There-
fore, although the amount of Ca2+ released from mito-
chondria by sAβ1–42 is small, it may play critical role in
the early stage of Ca2+ signaling. In this study, we also
found that sAβ1–42-induced Ca
2+ release from mitochon-
dria without extracellular Ca2+ influx was sufficient to in-
crease S9 phosphorylation of synapsin, indicating that
small amount of Ca2+ release from mitochondria could
sufficiently regulate the intersynaptic vesicle trafficking.
However, unlike FCCP, TPP pretreatment did not com-
pletely block the sAβ1–42-induced Ca
2+ influx across the
membrane. These discrepancies may be due to the differ-
ences in the molecular mechanism of action, side effects
of drugs or dose dependent manners. FCCP, a mitochon-
dira proton gradient uncoupler, induces mitochondrial
Ca2+ release as a proton inophore [43]. On the contrary,
TPP specifically blocks both sodium-dependent and inde-
pendent Ca2+ efflux from mitochondria [44]. However,
TPP has around 50 times lower inhibitory constant (Ki)
value in sodium-dependent pathway than sodium-
independent pathway and it means that sodium-
dependent Ca2+ efflux is efficiently blocked by TPP [44].
In addition, previous study has showed that FCCP induces
release of Ca2+ from not only mitochondria but also other
non-mitochondrial Ca2+ sources [45]. Thus, we still
cannot completely rule out the other internal Ca2+ sources
Fig. 3 sAβ1–42 increases heterogeneity of presynaptic terminals. a-e Neurons were treated as indicated and immunostained for endogenous
synaptophysin and bassoon. a Representative immunocytochemistry images (scale bar = 2 μm). b The number of presynaptic boutons were counted
along the axon (Average bouton numbers per 100 μm axon length: 35.54±1.43 for control, 34.57±0.97 for sAβ1–42, and 37.92±1.53 for sAβ1–42 with
6E10 (n = 4 independent experiments for each group)). c The intensity of bassoon puncta (> 80,000) was measured and presented with the
box plot. d The intensity profiles of synaptophysin-stained boutons were fitted into gamma distribution with a fixed shape parameter α = 4.
The scale parameter β was as follows: Control = 29.56 (81,356 boutons); sAβ1–42 = 40.70 (89,599 boutons); sAβ1–42 with 6E10 = 28.20 (83,369 boutons).
e Raw data of (d) were fitted to gamma function and their mean bouton intensity (α x β) and variance (α x β2) were measured. Values
are means±SEM. N.S = no significant difference, ** p < 0.01 (ANOVA and Tukey’s HSD post hoc test)
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for sAβ1–42-induced cytosolic Ca
2+ elevation. Specifically,
ER can have a significant role because ER and mitochon-
dria work together to regulate intracellular Ca2+ levels
[46]. In addition, previous study has shown that sAβ1–42
forms a cation-selective channels on the membrane and
Zn2+ treatment can block the open pore [47]. Therefore,
we tried to test the blockade effect of Zn2+ in the sAβ1–42-
induced cytosolic Ca2+ elevation. However, preincubation
of Zn2 + largely increased basal Fluo-4 AM intensity (data
not shown) and thus experiment could not proceed any
further. However, our results strongly suggested that the
mitochondrial Ca2+ release by sAβ1–42 plays an important
role in cytosolic Ca2+ elevation and synapsin
phosphorylation.
Although previous studies have showed that synaptic
vesicles are shared constitutively between presynaptic
terminals [24, 48], little is known about their functional
roles and regulation mechanisms. One key aspect of
vesicle sharing is its significant role in a variety of differ-
ent forms of plasticity. We found that sAβ1–42 strongly
inhibited activity-dependent rapid synaptogenesis, sug-
gesting that inhibition of intersynaptic vesicle trafficking
could be one of the cellular mechanisms underlying the
sAβ1–42-induced defects in synaptic plasticity [49].
Conversely, this type of mechanism for allocating synap-
tic weights across multiple neighboring synapses could
contribute to presynaptic homeostatic rescaling or
balancing of SV pool size among synapses. In this study,
we demonstrated that sAβ1–42 disrupted the regulatory
mechanism of balancing SV pool sizes between
presynaptic terminals by inhibiting intersynaptic vesicle
sharing and thus increases the heterogeneity in SV pool
size. In either case, the inhibition of intersynaptic
trafficking caused by sAβ1–42 alters synaptic strength
and efficacy, leading to the defects in synaptic plasticity
and homeostatic regulation, which could contribute to
synaptic dysfunctions observed in early AD.
Finally, although the in vitro system used in this study
does not mimic the exact disease state that underlies
AD, our results identify the novel sAβ1–42-induced de-
fect in presynaptic function associated with the early
stages of AD. Therefore, this work suggests a possible
therapeutic target that prevents sAβ1–42-induced synap-
tic dysfunction in early-stage AD.
Methods
sAβ1–42 preparation and treatment
sAβ1–42 was prepared from synthetic Aβ1–42 peptide
(Bachem) as previously described [27, 50, 51]. Briefly,
1 mM HFIP (1,1,1,3,3,3-hexafluoro-2-propanol, Sigma)
was added to dissolve synthetic Aβ1–42 peptide and incu-
bated at room temperature (RT) for 1 h. Then, HFIP was
evaporated and dried from aliquots to make peptide film.
Peptide film was dissolved in 1 mM dimethyl sulfoxide
(DMSO) and Ham’s F-12 (phenol red-free, ThermoFisher
scientific) was added for dilution and incubated over 12 h
at 4 °C for oligomerization. sAβ1–42 oligomer was
confirmed by western-blot before experiments. Unless
otherwise indicated, prepared sAβ1–42 was diluted with
cultured neurobasal media to the final concentration of
200 nM and treated to neurons for 2 h. To eliminate the
sAβ1–42 effects, diluted sAβ1–42 was preincubated with Aβ
antibody, 6E10 (Covance) for 2 h before treatment.
Antibodies
Anti-bassoon (cat# ab82958, Abcam), anti-synaptophysin 1
(cat# 101011, Synaptic Systems), anti-phospho-S9-synapsin
(cat# 2311, Cell Signaling Technology), anti-synapsin I
(cat# 106103, Synaptic Systems), anti-phospho-Thr196-
CaMKIV (cat# Sc-28,443-R, Santa Cruz Biotechnology),
anti-CaMKIV (cat# ab3557, Abcam), anti-mCherry (cat#
ab167453, Abcam), anti-actin (cat# A4700, Sigma) and
6E10 antibody (cat# SIG-39300, Covance) were used in the
experiments.
Hippocampal neuron culture and transfection
Hippocampal neurons were derived from embryonic day
18 fetal Sprague-Dawley rats and transfected at day in
vitro 8 (DIV8) as previously described [27]. Briefly,
dissociated hippocampal neurons were plated on poly-D-
lysine coated glass coverslips and grown in the neurobasal
medium supplemented with 2% B-27 (ThermoFisher
scientific), 0.5 mM L-glutamine (Gibco) and 4 μM
cytosine-1-β-D-arabinofuranoside (Ara-C; Sigma). At
DIV8, neurons were transfected using the modified Ca2+
phosphate method. Briefly, 6 μg of DNA and 9.3 μl of 2 M
CaCl2 were mixed in distilled water to a total volume of
75 μl, and the same volume of 2 × BBS [50 mM BES,
280 mM NaCl, and 1.5 mM Na2HPO4, pH 7.1] was added.
The cell culture medium was completely replaced by
transfection medium [minimum essential medium (MEM)
1 mM pyruvate, 0.6% glucose, 10 mM glutamine, and
10 mM HEPES, pH 7.65], and the DNA mixture was
added to the cells and incubated in a 5% CO2 incubator
for 60 min. Cells were washed twice with washing
medium (pH 7.35) and then returned to the original
culture medium. All animal experiments were approved
by the Institute of Animal Care and Use Committee of
Seoul National University, Korea.
HEK293T cell transfection
HEK293T cells were transfected by Lipofectamine-2000
reagent (ThermoFisher scientific) following the manufac-
turer’s instruction. Briefly, 3 μg of plasmid DNA were
mixed with 6 μl of Lipofectamine-2000 in the 200 μl of
Opti-MEM solution (ThermoFisher scientific) followed by
20 min incubation at RT. Then, mixture was treated to
HEK293T cells (60~ 70% confluency) in serum-free
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medium (Dulbecco’s Modified Eagle’s Medium, DMEM)
for 3 h and the medium was replaced by complete
medium (DMEM with 10% FBS). After 48 h, the cells were
lysed for western blot.
Immunocytochemistry
Cultured neurons were fixed in 4% paraformaldehyde in
4% sucrose/PBS for 15 min at RT and permeabilized
with 0.25% triton X-100 solution for 5 min at RT. After
permeabilization, neurons were blocked with 10% BSA/
PBS for 30 min at RT. Then, neurons were incubated
with primary antibody in 3% BSA/PBS for 2 h at RT and
with Alexa Fluor conjugated secondary antibody in 3%
BSA/PBS for 45 min at RT.
FRAP assay
Cultured hippocampal neurons were transfected with GFP-
synapsin and fluorescence recovery after photobleaching
(FRAP) assay was performed on a Fluoview-1000 confocal
microscope (Olympus) with a 100 x, 1.4 N.A. objective lens.
Neurons were incubated in pre-warmed tyrode solution
[136 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 1.3 mM MgCl2,
10 mM HEPES and 10 mM glucose], and single bouton
was bleached to 50% of the original fluorescence intensity
by scanning with a 488 nm laser at 50% of total laser power
for 2 s. Time-lapse images were acquired every 5 s for 150 s
and analyzed by using Olympus Fluoview software and
OriginPro 9.0 (OriginLab).
Synaptic vesicle tracking and analysis
GFP-synaptophysin expressing neurons were time-lapse
imaged for 1 min with 0.5 s intervals to track the synap-
tic vesicle movements. Each x and y coordination of
synaptic vesicles in time-lapse images was acquired
using MetaMorph software (Molecular Devices) and the
mean square displacement (MSD) was calculated using
formula below [27, 52].
MSD nτð Þ ¼ 1
N−n
XN−n
i¼1 x iþ nð Þτð Þ−x iτð Þð Þ
2 þ y iþ nð Þτð Þ−y iτð Þð Þ2 
xi and yi are coordinates of synaptic vesicle, N is the
total number of steps in the trajectory and τ is the
acquisition time. First five points of the MSD versus
time were linear-fitted and the diffusion coefficient was
calculated using the equation MSD (nτ) ≈ 4Dnτ.
Image acquisition and data analysis
Time-lapse images were acquired with an Olympus IX-71
inverted microscope (Olympus) with 40 x oil lens
(1.0 N.A.) using an Andor iXon 897 EMCCD camera
(Andor Technologies) and Touchbright LED light source
(LCI) controlled by MetaMorph software. Tyrode solution
included 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione
to prevent any recurrent excitation. Analysis and
quantification of data were performed with Meta-
Morph software, ImageJ (NIH) and OriginPro 9.0 in a
double- blind manner to avoid experimenter bias.
Statistical comparisons were performed with Origin
9.0 and SPSS (IBM) software. Student’s t test was per-
formed for comparisons between two independent groups.
For multiple group comparison, one-way ANOVA
followed by Tukey’s post hoc test was performed.
Ca2+ measurements
To detect the Ca2+ dynamics, cultured neurons were incu-
bated with 0.5 μM Fluo-4 AM Ca2+ indicator (F14201,
ThermoFisher scientific) for 15 min at 37 °C. After 10 min
of wash-out in tyrode, Fluo-4 AM intensity was measured
before and after 5 min treatment of sAβ1–42. To see the
blockage effect of TPP (Sigma), Fluo-4 AM loaded
neurons were pre-incubated with extracellular buffer as
indicated (normal tyrode (2 mM Ca2+), Ca2+-free tyrode
containing EDTA, normal tyrode containing 2 μM TPP,
Ca2+-free tyrode containing EDTA and 2 μM TPP)
for 5 min and the changes in Fluo-4 AM intensity
after sAβ1–42 or TPP treatment were measured by
time-lapse imaging (5 s intervals). To confirm the
levels of synapsin phosphorylation induced by sAβ1–42
in 0 mM extracellular Ca2+, neurons were each treated
with DMSO, 2 μM TPP, 200 nM sAβ1–42, or 200 nM
sAβ1–42 with 2 μM TPP for 2 h in Ca
2+-free tyrode con-
taining EDTA. After then, neuron lysates from each treat-
ment group were western blotted to measure the level of
phospho- and total-synapsin I.
Immunoprecipitation
Transfected HEK293T cells were lysed in a 1% triton X-
100 lysis buffer [20 mM Tris-HCl, pH 8, 1% triton X-100,
10% glycerol, 137 mM NaCl, 2 mM EDTA] with 1% seine/
threonine phosphatase inhibitor (Sigma) and protease
inhibitor cocktail (Sigma). After sonication and centrifuga-
tion, anti-synapsin I antibody (Synaptic Systems) was
added to each of equal amounts of total cell lysate
(500 μg). The samples were incubated overnight at 4 °C,
then 30 μl Protein A-Sepharose (GE healthcare) was
added and incubated for 1 h at 4 °C. The samples were
washed three times with lysis buffer and then bead pellets
were eluted with 30 μl of 2× sample buffer [100 mM
Tris-HCl (pH 6.8), 4% sodium dodecyl sulfate, 0.2%
bromophenol blue, 20% glycerol and 2% beta-
mercaptoethanol] followed by boiling (100 °C, 5 min) and
gel loading.
Western blot
Cultured rat hippocampal neurons at DIV14–16 were
lysed with 1% triton X-100 lysis buffer with 1% seine/
threonine phosphatase inhibitor (Sigma) and protease
inhibitor cocktail (Sigma). Lysates were centrifuged at
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14,000 g at 4 °C for 20 min after sonication. Supernatants
were collected and protein concentration was measured
using BCA assay kit. Equal amounts of protein were
loaded on to polyacrylamide gels. Gels were transferred to
PVDF membranes (Pall Life Sciences, Ann Arbor, MI),
then the membranes were incubated with 10% BSA/PBS
or 5% SKIM milk/PBS for 30 min at RT. After washing in
TBST, PVDF membranes were incubated with the primary
antibody for overnight at 4 °C, followed by the horseradish
peroxidase (HRP)-conjugated secondary antibody
(Jackson ImmunoResearch Laboratories, West Grove, PA)
for 1 h at RT. ECL solution (AbClon) and LAS 4000 (GE
healthcare) were used to detect immunoreaction. Band
intensities were calculated using imageJ.
Additional file
Additional file 1: Figure S1. Phospho-deficient mutants of synapsin
serine 9 (S9A) residue and actin binding. (a) Representative western blot
images for immunoprecipitation and total cell lysate. (b) Quantitative analysis
from 4 independent blots (1±0 for control, 1.94±0.27 for S9A). Values are
means±SEM. N.S = no significant difference, * p < 0.05 (Student’s t-test).
(PDF 345 kb)
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